Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Endogenous IL-1α from systemic sclerosis fibroblasts induces IL-6 and PDGF-A
Yasushi Kawaguchi, Masako Hara, Timothy M. Wright
Yasushi Kawaguchi, Masako Hara, Timothy M. Wright
View: Text | PDF
Article

Endogenous IL-1α from systemic sclerosis fibroblasts induces IL-6 and PDGF-A

  • Text
  • PDF
Abstract

It is reported that fibroblasts derived from clinically affected skin areas of patients with systemic sclerosis (SSc) have the ability to overproduce several cytokines and growth factors (i.e., IL-6, PDGF), an ability that might be involved in the pathogenesis of SSc. We have previously shown that the expression of IL-1α was constitutively observed in SSc fibroblasts, whereas this was not detected in normal fibroblasts. Although it was suggested that the aberrant IL-1α production could be associated with the fibrogenic phenotype of SSc fibroblasts, little is known about the roles of IL-1α in SSc fibroblasts. IL-1α induced IL-6 and PDGF-A, which are potent stimulators of collagen production and proliferation in normal fibroblasts. This article examines the proposal that IL-6 and PDGF-A are elevated through the action of endogenous IL-1α in SSc fibroblasts. An antisense oligodeoxynucleotide complementary to IL-1α mRNA was used to suppress endogenous IL-1α. Inhibition of endogenous IL-1α led to decreased levels of IL-6 and PDGF-A expression in SSc fibroblasts. Moreover, the blocking of the IL-6 response using anti–IL-6 antibody resulted in a significant reduction of procollagen type I in cultured SSc fibroblasts. These results suggest that endogenous IL-1α expressed by SSc fibroblasts may play a key role in the abnormal function of SSc fibroblasts through the expression of IL-6 and PDGF-A.

Authors

Yasushi Kawaguchi, Masako Hara, Timothy M. Wright

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
(a) Production of IL-1α in affected and unaffected fibroblasts from pati...
(a) Production of IL-1α in affected and unaffected fibroblasts from patients with SSc and in normal fibroblasts. Fibroblasts were cultured in serum-free media for 24 hours, and cell lysates were collected. IL-1α concentrations in cell lysates were measured by an ELISA kit. The results are expressed as the mean ± SD. Asterisks indicate IL-1α concentrations below the sensitivity of the ELISA kit used. (b) Effect of antisense ODN complementary to IL-1α mRNA on IL-1α production in SSc-affected fibroblasts (n = 9). SSc-affected fibroblasts were cultured in serum-free medium with various concentrations of sense (open circles) or antisense (filled circles) ODN for 48 hours. Cell lysates were collected, and IL-1α production was measured using an ELISA kit. The results are expressed as the mean ± SD of IL-1α production. *P < 0.05, **P < 0.01 compared with sense ODN (control) by paired Student’s t test. (c) Time course of IL-1α production in SSc-affected fibroblasts treated with IL-1α antisense ODN. SSc-affected fibroblasts (n = 6) were cultured in serum-free medium with 20 μM of sense (filled bars) or antisense (open bars) ODN for the indicated time. Cell lysates were extracted, and IL-1α production was measured using an ELISA kit. The results are expressed as the mean ± SD of IL-1α production. *P < 0.05 compared with sense ODN (control) by paired Student’s t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts